Capital Fund Management (CFM) Portfolio holdings
AUM
$9.06B
1-Year Return
3.46%
This Quarter Return
+2%
1 Year Return
+3.46%
3 Year Return
+12.89%
5 Year Return
+19.14%
10 Year Return
+34.42%
AUM
$9.06B
AUM Growth
+$1.22B
(+16%)
Cap. Flow
+$617M
Cap. Flow
% of AUM
6.81%
Top 10 Holdings %
Top 10 Hldgs %
17.95%
Holding
1,328
New
269
Increased
318
Reduced
245
Closed
179
Top Buys
| 1 |
Apple
AAPL
|
+$270M |
| 2 |
NVIDIA
NVDA
|
+$261M |
| 3 |
UnitedHealth
UNH
|
+$150M |
| 4 |
Chevron
CVX
|
+$83.1M |
| 5 |
McDonald's
MCD
|
+$80.2M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$136M |
| 2 |
JPMorgan Chase
JPM
|
+$128M |
| 3 |
Advanced Micro Devices
AMD
|
+$71.9M |
| 4 |
Qualcomm
QCOM
|
+$64M |
| 5 |
Morgan Stanley
MS
|
+$63M |
Sector Composition
| 1 | Technology | 21.95% |
| 2 | Financials | 15.21% |
| 3 | Healthcare | 14.7% |
| 4 | Consumer Discretionary | 13.14% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Delta Air Lines
DAL
$40.1B
| $547K | ﹤0.01% |
11,113
-315,260
| -97% | -$15.5M |
|
802
REV Group
REVG
$3.06B
| $540K | ﹤0.01% |
+11,352
| New | +$540K |
|
803
Halliburton
HAL
$19.3B
| $510K | ﹤0.01% |
25,037
+13,057
| +109% | +$266K |
|
804
Vericel Corp
VCEL
$1.58B
| $502K | ﹤0.01% |
+11,790
| New | +$502K |
|
805
PG&E
PCG
$33.5B
| $500K | ﹤0.01% |
+35,858
| New | +$500K |
|
806
Southwest Airlines
LUV
$16.3B
| $495K | ﹤0.01% |
+15,272
| New | +$495K |
|
807
Oxford Industries
OXM
$604M
| $465K | ﹤0.01% |
+11,560
| New | +$465K |
|
808
BioCryst Pharmaceuticals
BCRX
$1.68B
| $465K | ﹤0.01% |
+51,913
| New | +$465K |
|
809
Star Bulk Carriers
SBLK
$2.23B
| $460K | ﹤0.01% |
26,678
-49,085
| -65% | -$847K |
|
810
Clearway Energy Class C
CWEN
$3.35B
| $454K | ﹤0.01% |
+14,177
| New | +$454K |
|
811
Liberty Global Class C
LBTYK
$3.99B
| $453K | ﹤0.01% |
43,966
+24,489
| +126% | +$252K |
|
812
Gaotu Techedu
GOTU
$865M
| $450K | ﹤0.01% |
124,594
| – | – |
|
813
Rayonier
RYN
$4.04B
| $448K | ﹤0.01% |
+20,193
| New | +$448K |
|
814
Integra LifeSciences
IART
$1.2B
| $433K | ﹤0.01% |
+35,325
| New | +$433K |
|
815
Edgewell Personal Care
EPC
$1.01B
| $432K | ﹤0.01% |
+18,473
| New | +$432K |
|
816
Valley National Bancorp
VLY
$5.99B
| $425K | ﹤0.01% |
+47,623
| New | +$425K |
|
817
Crinetics Pharmaceuticals
CRNX
$3.3B
| $424K | ﹤0.01% |
+14,741
| New | +$424K |
|
818
RXO
RXO
$2.74B
| $417K | ﹤0.01% |
+26,543
| New | +$417K |
|
819
Aspen Aerogels
ASPN
$516M
| $415K | ﹤0.01% |
70,048
-310,101
| -82% | -$1.84M |
|
820
Rapid7
RPD
$1.26B
| $408K | ﹤0.01% |
+17,647
| New | +$408K |
|
821
CoreCivic
CXW
$2.18B
| $397K | ﹤0.01% |
+18,859
| New | +$397K |
|
822
Healthpeak Properties
DOC
$12.5B
| $359K | ﹤0.01% |
+20,482
| New | +$359K |
|
823
Denali Therapeutics
DNLI
$2.14B
| $306K | ﹤0.01% |
+21,871
| New | +$306K |
|
824
Structure Therapeutics
GPCR
$1.2B
| $298K | ﹤0.01% |
14,350
-65,306
| -82% | -$1.35M |
|
825
DHT Holdings
DHT
$1.94B
| $290K | ﹤0.01% |
26,789
-76,697
| -74% | -$829K |
|